Training for those who administer cosmetic injections is lacking, despite significant growth in demand for fillers in the ...

Patients with comorbid autoimmune bullous disease and acquired hemophilia A who were of older age were significantly associated with mortality.

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

Pediatric and OB-GYN health care providers react to HHS Secretary Robert F. Kennedy Jr’s announcement on COVID-19 vaccine recommendations.

Routine HPV vaccination at 9 to 10 years may decrease concerns about sexual activity without increasing other burdens.

The Trump administration rescinded a mandate requiring all Medicare-funded hospitals to provide life-saving emergency abortions.

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.

Dr Vivek Murthy has pushed for Congress to support bills requiring social media companies to implement restrictions on children's content.

Bimekizumab demonstrated a favorable safety profile for the long-term treatment of axSpA and PsA, with rates of TEAEs remaining stable over time.

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Adolescents with alopecia areata experience a greater effect on quality of life than adults when experiencing 50% or greater scalp hair loss.

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.